fashion -WSS

fashion

author：leisure time 2025-10-02 19:39:24 - browse：94

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Allen Institute goes after foundational questions, CEO Costa says

explore

WSS

American taxpayers paid $1.8 trillion in health care costs in 2022

Arena BioWorks launches in Cambridge to speed drug discovery

Physician assistants need a new name. Here's what it should be

CDC wastewater surveillance dashboard to track bird flu hotspots

Allen Institute goes after foundational questions, CEO Costa says

Bird flu outbreak in cows is latest avian flu curveball

hotspot

fashion

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Life science postdocs should get big pay hike, NIH panel says

Cancer drug shortages should be causing more outrage

Gene therapy denied for Afghan refugee whose father aided U.S.

New air purifier tech could be key to improving indoor air quality

Life science postdocs should get big pay hike, NIH panel says

Apple is now the first public company to be valued at $3 trillion

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Sports medicine is finally prioritizing gender equality

Stories you might have missed in 2023: health, science, medicine

knowledge

H5N1 bird flu: what we're starting to learn about infection in cows

Arena BioWorks launches in Cambridge to speed drug discovery

A preacher's new calling: Diversifying neuroscience research

Telehealth startups turn to complex chronic diseases

Readout LOUD podcast: What to know about H5N1 bird flu

First recipient of genetically engineered pig kidney has died

focus

explore

knowledge

knowledge